+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cardiovascular Surgery Devices Market by Product, End User, Technology, Procedure, Application - Global Forecast to 2030- Product Image
Cardiovascular Surgery Devices Market by Product, End User, Technology, Procedure, Application - Global Forecast to 2030- Product Image
Sale

Cardiovascular Surgery Devices Market by Product, End User, Technology, Procedure, Application - Global Forecast to 2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010724
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cardiovascular Surgery Devices Market grew from USD 1.65 billion in 2024 to USD 1.74 billion in 2025. It is expected to continue growing at a CAGR of 5.51%, reaching USD 2.28 billion by 2030.

Exploring the Evolution of Cardiovascular Surgical Devices

The domain of cardiovascular surgery devices stands at the forefront of medical innovation, driven by the imperative to improve patient outcomes and address the growing burden of cardiovascular diseases. As demographic shifts and rising prevalence of heart-related ailments converge, surgical interventions increasingly rely on advanced instrumentation and consumables. From the precise cannulation of arterial and venous pathways to the intricate deployment of vascular grafts, each device plays a critical role in enabling surgeons to navigate complex anatomies with greater safety and efficacy.

In recent years, the market has witnessed an influx of technological breakthroughs that have challenged traditional paradigms of open-heart surgery. Enhanced biomaterials, refined hemostatic agents, and state-of-the-art oxygenation systems have collectively reduced procedural risk and accelerated patient recovery. Meanwhile, innovations in sternal closure and cardiovascular sutures continue to secure postoperative integrity and minimize complications. This landscape of continuous advancement underscores the importance of strategic investments in research, regulatory alignment, and global supply chain optimization. As stakeholders navigate this dynamic environment, understanding the forces at play will be critical for capitalizing on emerging opportunities and sustaining competitive advantage.

Unleashing Drivers Redefining the Surgical Device Landscape

Over the past decade, the cardiovascular surgery device segment has undergone transformative changes propelled by technological breakthroughs and shifting clinical practices. Minimally invasive techniques have steadily displaced open surgical methods, enabling smaller incisions and faster patient recovery without compromising procedural success. Robotics assisted surgery has further elevated precision, granting surgeons unprecedented control during intricate maneuvers. Concurrently, digital integration through smart sensors and data analytics is unlocking real-time performance monitoring, predictive maintenance of equipment, and optimization of perioperative workflows.

Beyond technology, evolving patient expectations and regulatory scrutiny are reshaping market dynamics. Increasing demand for customizable grafts and personalized hemostatic agents reflects a broader shift toward patient-centric care. Regulatory bodies are reinforcing quality standards and post-market surveillance, ensuring that new device entrants adhere to stringent safety profiles. As a result, manufacturers are compelled to adopt agile development cycles and robust clinical validation strategies. These converging forces are redefining competitive benchmarks and setting the stage for next-generation devices that seamlessly blend engineering excellence with clinical efficacy.

Assessing the Consequences of US Tariffs on Device Costs

In 2025, the U.S. government’s imposition of additional tariffs on select cardiovascular surgery devices has created a ripple effect across the entire value chain. Import costs for critical components such as oxygenators and specialized cannulas surged, forcing manufacturers to reevaluate sourcing strategies and pricing frameworks. Some original equipment producers have absorbed part of the increased expense to shield end users, while others passed through higher costs, leading to pronounced price volatility in hospital budgets.

This sudden recalibration has accelerated the movement toward near-shoring and regional manufacturing hubs. Suppliers are forging partnerships with domestic contract manufacturers to mitigate exposure to cross-border duties. Clinicians and procurement teams, in turn, are scrutinizing device portfolios for cost-effective alternatives, shifting preference toward products with lower international content. Although these adaptations have stabilized supply in the short term, the long-term impact on innovation pipelines and capital allocation remains under close watch. As tariff policies evolve, stakeholders must remain vigilant in balancing cost efficiencies with the imperative to maintain clinical excellence.

Decoding Segmentation Patterns Shaping Market Dynamics

Insights drawn from a granular analysis of market segmentation reveal distinct growth trajectories and strategic imperatives across each cohort. When viewed through the lens of product categories, cannulas-encompassing arterial, cardioplegia and venous variants-are demonstrating robust uptake as surgical teams prioritize reliable perfusion pathways. Conversely, demand for vascular grafts oscillates between biological scaffolds prized for biocompatibility and synthetic options valued for longer shelf life. Cardiovascular sutures, divided into absorbable and nonabsorbable types, underscore a balance between tissue healing and long-term structural support, while sternal closure systems continue to evolve from traditional wiring networks to innovative clip-based mechanisms.

Examining end-user channels, hospitals-both public and private-remain the primary revenue drivers owing to high procedural volumes and comprehensive infrastructure. Ambulatory surgical centers, especially those integrated within hospital systems, are rapidly adopting streamlined devices suited to same-day discharge models. Cardiac specialty clinics and general clinics alike are expanding their repertoire of minimally invasive tools to accommodate outpatient therapies. On the technology front, the shift from conventional open surgery toward minimally invasive and robotics assisted approaches underscores a broader clinical preference for reduced trauma and enhanced procedural precision. Procedural segments reflect a spectrum of complexity, spanning aneurysm repair and dissection repair in aortic surgery to multi-valve replacement in the tricuspid, mitral and aortic positions. Finally, requirement for specialized devices diverges by patient group, with distinct considerations for adult cardiac interventions versus neonatal and pediatric cardiac repairs.

Unearthing Regional Variations in Cardiovascular Surgery

Geographic analysis underscores pronounced disparities in adoption rates and procurement strategies across key regions. The Americas exhibit sustained leadership driven by established infrastructure and a favorable reimbursement environment, with North American centers pioneering next-generation device trials. Meanwhile, Latin American markets are characterized by increasing public-private collaborations aimed at bolstering access to advanced surgical technologies.

Across Europe, Middle East and Africa, diverse regulatory frameworks and economic profiles dictate varied market maturities. Western European nations leverage centralized health systems to negotiate favorable pricing and standardize device portfolios, whereas regions in the Middle East and Africa are focused on building foundational surgical capabilities through targeted investments and training partnerships. In the Asia-Pacific region, surging healthcare expenditures alongside expanding insurance coverage fuel demand for cost-competitive devices. Local manufacturing initiatives in key economies are reshaping global supply chains, while rapid uptake of minimally invasive and robotics assisted platforms signals a leapfrogging effect in clinical practice standards.

Spotlighting Leading Innovators in Cardiac Surgery Equipment

A handful of global players dominate the cardiovascular surgery device landscape, each bringing distinctive strengths to the competitive arena. One leading manufacturer commands significant share in sternal closure systems and cardiopulmonary bypass equipment, backed by an extensive service network and rapid response capabilities. A second multinational is establishing leadership in oxygenators and flowable hemostatic agents, driven by proprietary membrane technologies and robust clinical trial data. Meanwhile, an established cardiac specialist has expanded its portfolio through strategic acquisitions, integrating synthetic graft solutions with advanced suturing platforms.

Smaller innovators and start-ups are also carving niches by focusing on robotics assisted instruments and next-generation biomaterials. Collaboration between device makers and research institutions has yielded breakthroughs in bioresorbable stents and patient-specific graft fabrication. As patent expirations create openings for generic alternatives, new entrants are exploring cost-effective production methods without sacrificing quality standards. This competitive mosaic underscores the importance of agility, robust R&D pipelines and comprehensive customer support in sustaining market leadership.

Strategic Imperatives for Industry Leadership in Cardiac Devices

Industry leaders seeking to capitalize on emerging opportunities must adopt a multifaceted strategy that aligns innovation with market realities. First, strengthening clinical partnerships and co-development agreements with leading cardiovascular centers accelerates device refinement and validation. By involving surgeons early in the design process, manufacturers can ensure seamless integration with evolving procedural protocols.

Second, diversification of manufacturing footprints through regional alliances or joint ventures mitigates tariff exposure and enhances supply chain resilience. Establishing localized assembly or component production centers can yield cost savings while fostering goodwill among procurement stakeholders. Third, investing in digital health capabilities-such as predictive maintenance, procedural analytics and remote training modules-differentiates product offerings and elevates the total value proposition. Finally, proactive engagement with regulatory bodies and reimbursement agencies facilitates faster market access and clarifies pathway requirements for novel therapies. By prioritizing these strategic imperatives, organizations can secure competitive advantages and drive sustainable growth.

Ensuring Rigor Through a Robust Research Framework

This analysis draws upon a robust combination of primary and secondary research methodologies. Primary data were gathered through in-depth interviews with cardiovascular surgeons, procurement executives, and regulatory experts across major geographies. Secondary sources-including peer-reviewed journals, clinical trial registries, and industry white papers-provided contextual understanding of evolving technologies and policy developments.

Data triangulation was employed to validate findings and reconcile discrepancies between diverse information streams. A structured framework guided qualitative and quantitative assessments across product categories, end-user segments, regional markets, and competitive landscapes. To ensure methodological rigor, all data inputs underwent multiple rounds of cross-verification and peer review. The segmentation approach aligns with widely recognized industry taxonomies, facilitating coherent comparisons and strategic insights.

Converging Insights Toward a Unified Market Perspective

In synthesizing the multifaceted trends shaping the cardiovascular surgery devices market, a clear narrative emerges: the interplay of technological innovation, regulatory dynamics, and global trade policies is redefining competitive benchmarks. Advanced perfusion systems and refined graft materials are no longer optional; they are essential enablers of clinical excellence. Simultaneously, the ripple effects of tariffs and regional manufacturing shifts underscore the importance of adaptable supply chain strategies. As segmentation insights reveal, each product type and end-user channel follows its own trajectory, demanding tailored go-to-market approaches.

Looking ahead, organizations that harmonize innovation with cost efficiency and regulatory compliance will lead the next wave of market disruption. By staying informed of regional nuances and aligning R&D investments with clinician needs, stakeholders can unlock new growth avenues and deliver enhanced patient outcomes. Ultimately, a holistic understanding of these converging forces will empower decision-makers to navigate uncertainty and build resilient, future-proof enterprises.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product
    • Cannulas
      • Arterial
      • Cardioplegia
      • Venous
    • Cardiovascular Sutures
      • Absorbable
      • Nonabsorbable
    • Heart Lung Machines
    • Hemostats
      • Flowable
      • Topical
    • Oxygenators
      • Bubble
      • Membrane
    • Sternal Closure Devices
      • Clips
      • Wiring Systems
    • Vascular Grafts
      • Biological
      • Synthetic
  • End User
    • Ambulatory Surgical Centers
      • Hospital Owned
      • Independent
    • Clinics
      • Cardiac Specialty Clinics
      • General Clinics
    • Hospitals
      • Private
      • Public
  • Technology
    • Conventional Surgery
    • Minimally Invasive Surgery
    • Robotics Assisted Surgery
  • Procedure
    • Aortic Surgery
      • Aneurysm Repair
      • Dissection Repair
    • Congenital Heart Defect Repair
    • Coronary Artery Bypass Grafting
    • Valve Repair Replacement
      • Aortic Valve
      • Mitral Valve
      • Tricuspid Valve
  • Application
    • Adult Cardiac Surgery
    • Pediatric Cardiac Surgery
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Terumo Corporation
  • Getinge AB
  • LivaNova PLC
  • B. Braun Melsungen AG
  • Johnson & Johnson
  • Baxter International Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cardiovascular Surgery Devices Market, by Product
8.1. Introduction
8.2. Cannulas
8.2.1. Arterial
8.2.2. Cardioplegia
8.2.3. Venous
8.3. Cardiovascular Sutures
8.3.1. Absorbable
8.3.2. Nonabsorbable
8.4. Heart Lung Machines
8.5. Hemostats
8.5.1. Flowable
8.5.2. Topical
8.6. Oxygenators
8.6.1. Bubble
8.6.2. Membrane
8.7. Sternal Closure Devices
8.7.1. Clips
8.7.2. Wiring Systems
8.8. Vascular Grafts
8.8.1. Biological
8.8.2. Synthetic
9. Cardiovascular Surgery Devices Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.2.1. Hospital Owned
9.2.2. Independent
9.3. Clinics
9.3.1. Cardiac Specialty Clinics
9.3.2. General Clinics
9.4. Hospitals
9.4.1. Private
9.4.2. Public
10. Cardiovascular Surgery Devices Market, by Technology
10.1. Introduction
10.2. Conventional Surgery
10.3. Minimally Invasive Surgery
10.4. Robotics Assisted Surgery
11. Cardiovascular Surgery Devices Market, by Procedure
11.1. Introduction
11.2. Aortic Surgery
11.2.1. Aneurysm Repair
11.2.2. Dissection Repair
11.3. Congenital Heart Defect Repair
11.4. Coronary Artery Bypass Grafting
11.5. Valve Repair Replacement
11.5.1. Aortic Valve
11.5.2. Mitral Valve
11.5.3. Tricuspid Valve
12. Cardiovascular Surgery Devices Market, by Application
12.1. Introduction
12.2. Adult Cardiac Surgery
12.3. Pediatric Cardiac Surgery
13. Americas Cardiovascular Surgery Devices Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Cardiovascular Surgery Devices Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Cardiovascular Surgery Devices Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Medtronic plc
16.3.2. Abbott Laboratories
16.3.3. Boston Scientific Corporation
16.3.4. Edwards Lifesciences Corporation
16.3.5. Terumo Corporation
16.3.6. Getinge AB
16.3.7. LivaNova PLC
16.3.8. B. Braun Melsungen AG
16.3.9. Johnson & Johnson
16.3.10. Baxter International Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CARDIOVASCULAR SURGERY DEVICES MARKET MULTI-CURRENCY
FIGURE 2. CARDIOVASCULAR SURGERY DEVICES MARKET MULTI-LANGUAGE
FIGURE 3. CARDIOVASCULAR SURGERY DEVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CARDIOVASCULAR SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CARDIOVASCULAR SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CARDIOVASCULAR SURGERY DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CANNULAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY ARTERIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPLEGIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY VENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CANNULAS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOVASCULAR SUTURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY ABSORBABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY NONABSORBABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOVASCULAR SUTURES, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART LUNG MACHINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY FLOWABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY OXYGENATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY BUBBLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY MEMBRANE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY OXYGENATORS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY STERNAL CLOSURE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CLIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY WIRING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY STERNAL CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY VASCULAR GRAFTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY BIOLOGICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HOSPITAL OWNED, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY INDEPENDENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIAC SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRIVATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PUBLIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY ROBOTICS ASSISTED SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY AORTIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY ANEURYSM REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY DISSECTION REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY AORTIC SURGERY, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CONGENITAL HEART DEFECT REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY VALVE REPAIR REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY AORTIC VALVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY MITRAL VALVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY TRICUSPID VALVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY VALVE REPAIR REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY ADULT CARDIAC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PEDIATRIC CARDIAC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CANNULAS, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOVASCULAR SUTURES, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY OXYGENATORS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY STERNAL CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY AORTIC SURGERY, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY VALVE REPAIR REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CANNULAS, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOVASCULAR SUTURES, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY OXYGENATORS, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY STERNAL CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY AORTIC SURGERY, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY VALVE REPAIR REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 99. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CANNULAS, 2018-2030 (USD MILLION)
TABLE 101. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOVASCULAR SUTURES, 2018-2030 (USD MILLION)
TABLE 102. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 103. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY OXYGENATORS, 2018-2030 (USD MILLION)
TABLE 104. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY STERNAL CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 105. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 106. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 108. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 109. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 110. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 111. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 112. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY AORTIC SURGERY, 2018-2030 (USD MILLION)
TABLE 113. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY VALVE REPAIR REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 114. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 116. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CANNULAS, 2018-2030 (USD MILLION)
TABLE 117. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOVASCULAR SUTURES, 2018-2030 (USD MILLION)
TABLE 118. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 119. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY OXYGENATORS, 2018-2030 (USD MILLION)
TABLE 120. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY STERNAL CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 121. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 122. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 124. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 125. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 126. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 127. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 128. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY AORTIC SURGERY, 2018-2030 (USD MILLION)
TABLE 129. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY VALVE REPAIR REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 130. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CANNULAS, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOVASCULAR SUTURES, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY OXYGENATORS, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY STERNAL CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY AORTIC SURGERY, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY VALVE REPAIR REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CANNULAS, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOVASCULAR SUTURES, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY OXYGENATORS, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY STERNAL CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 154. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 156. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 157. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 158. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 160. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY AORTIC SURGERY, 2018-2030 (USD MILLION)
TABLE 161. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY VALVE REPAIR REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 162. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CANNULAS, 2018-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOVASCULAR SUTURES, 2018-2030 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY OXYGENATORS, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY STERNAL CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY AORTIC SURGERY, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY VALVE REPAIR REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 180. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CANNULAS, 2018-2030 (USD MILLION)
TABLE 182. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOVASCULAR SUTURES, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY OXYGENATORS, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY STERNAL CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY AORTIC SURGERY, 2018-2030 (USD MILLION)
TABLE 194. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY VALVE REPAIR REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 197. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CANNULAS, 2018-2030 (USD MILLION)
TABLE 198. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOVASCULAR SUTURES, 2018-2030 (USD MILLION)
TABLE 199. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 200. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY OXYGENATORS, 2018-2030 (USD MILLION)
TABLE 201. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY STERNAL CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 202. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 203. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 205. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 206. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 207. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 208. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 209. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY AORTIC SURGERY, 2018-2030 (USD MILLION)
TABLE 210. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY VALVE REPAIR REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 211. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 213. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CANNULAS, 2018-2030 (USD MILLION)
TABLE 214. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOVASCULAR SUTURES, 2018-2030 (USD MILLION)
TABLE 215. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 216. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY OXYGENATORS, 2018-2030 (USD MILLION)
TABLE 217. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY STERNAL CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 218. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 219. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 221. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 222. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 223. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 224. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 225. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY AORTIC SURGERY, 2018-2030 (USD MILLION)
TABLE 226. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY VALVE REPAIR REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 227. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CANNULAS, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOVASCULAR SUTURES, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY OXYGENATORS, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY STERNAL CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 235. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 236. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 237. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 238. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 239. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 240. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 241. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY AORTIC SURGERY, 2018-2030 (USD MILLION)
TABLE 242. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY VALVE REPAIR REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 243. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 245. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CANNULAS, 2018-2030 (USD MILLION)
TABLE 246. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOVASCULAR SUTURES, 2018-2030 (USD MILLION)
TABLE 247. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 248. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY OXYGENATORS, 2018-2030 (USD MILLION)
TABLE 249. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY STERNAL CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 250. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 251. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 253. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 254. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 255. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 256. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 257. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY AORTIC SURGERY, 2018-2030 (USD MILLION)
TABLE 258. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY VALVE REPAIR REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 259. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 260. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 261. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CANNULAS, 2018-2030 (USD MILLION)
TABLE 262. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOVASCULAR SUTURES, 2018-2030 (USD MILLION)
TABLE 263. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 264. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY OXYGENATORS, 2018-2030 (USD MILLION)
TABLE 265. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY STERNAL CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 266. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 267. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 268. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 269. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 270. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 271. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 272. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 273. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY AORTIC SURGERY, 2018-2030 (USD MILLION)
TABLE 274. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY VALVE REPAIR REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 275. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CANNULAS, 2018-2030 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOVASCULAR SUTURES, 2018-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY OXYGENATORS, 2018-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY STERNAL CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY AORTIC SURGERY, 2018-2030 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY VALVE REPAIR REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 292. SAUDI ARABIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 293. SAUDI ARABIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CANNULAS, 2018-2030 (USD MILLION)
TABLE 294. SAUDI ARABIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOVASCULAR SUTURES, 2018-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 296. SAUDI ARABIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY OXYGENATORS, 2018-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY STERNAL CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 298. SAUDI ARABIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. SAUDI ARABIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 302. SAUDI ARABIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 201

Companies Mentioned

The companies profiled in this Cardiovascular Surgery Devices market report include:
  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Terumo Corporation
  • Getinge AB
  • LivaNova PLC
  • B. Braun Melsungen AG
  • Johnson & Johnson
  • Baxter International Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages185
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.74 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.28 Billion
Compound Annual Growth Rate5.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Cardiovascular Surgery Devices and Equipment Market Report 2025 - Product Image

Cardiovascular Surgery Devices and Equipment Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Cardiovascular Surgery Devices - Global Strategic Business Report - Product Image

Cardiovascular Surgery Devices - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Cardiovascular Surgical Devices Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Image

Cardiovascular Surgical Devices Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • 120 Pages
  • Global
From
Cardiovascular Surgery Devices Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Cardiovascular Surgery Devices Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 151 Pages
  • Global
From
Cardiac Surgery Instruments - Global Strategic Business Report - Product Image

Cardiac Surgery Instruments - Global Strategic Business Report

  • Report
  • 188 Pages
  • Global
From

About the Cardiovascular Surgical Device Market

The Cardiovascular Surgical Device market is a subset of the larger Cardiovascular Devices market. It includes a range of products used in the diagnosis and treatment of cardiovascular diseases, such as heart valves, stents, and catheters. These devices are used to diagnose and treat a variety of cardiovascular conditions, including coronary artery disease, heart failure, and arrhythmias. They are also used to perform minimally invasive procedures, such as angioplasty and bypass surgery. The Cardiovascular Surgical Device market is highly competitive, with a number of major players offering a wide range of products. Companies in the market include Medtronic, Abbott, Boston Scientific, Edwards Lifesciences, and Johnson & Johnson. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.